Table 1 Clinical characteristics and operation-related variables of the study participants
Characteristics | 23G | 25G | p-value |
|---|---|---|---|
Eyes, n | 70 | 97 | |
Male, n(%) | 43 (61.4) | 60 (61.9) | 0.955 |
Age, years (mean ± SD) | 54.70 ± 11.31 | 51.63 ± 12.74 | 0.109 |
Preoperative systolic blood pressure,mmHg (mean ± SD) | 138.01 ± 18.42 | 136.13 ± 20.17 | 0.539 |
Diabetes | |||
Duration, years | 10.00 (5.00–15.00) | 12.00 (6.50–16.50) | 0.041 |
Preoperative fasting blood glucose level, mmol/L | 5.62 (4.70–7.41) | 5.96 (5.05–7.19) | 0.639 |
Serum creatinine, μmol/L | 77.55 (58.78–104.93) | 76.00 (59.15–127.00) | 0.359 |
Urea, mmol/L | 6.51 (5.41–8.88) | 6.67 (4.81–8.90) | 0.502 |
Triamcinolone acetonide usage, n(%) | 63 (90.0) | 59 (60.8) | < 0.001 |
Elctral-coagulation usage, n(%) | 12 (17.1) | 7 (7.2) | 0.046 |
Air-fluid exchange, n(%) | 66 (94.3) | 66 (68.0) | < 0.001 |
Pre-pan-retinal photocoagulation, n(%) | 12 (17.1) | 15 (15.5) | 0.771 |
Anti-vascular endothelial growth drug usage, n(%) | 10 (14.3) | 33 (34.0) | 0.004 |
Intraocular pressure, mmHg | |||
preoperative IOP | 16.45 (15.38–17.53) | 16.40 (14.25–17.40) | 0.092 |
postoperative IOP | 16.00 (14.93–16.78) | 15.31 (14.25–16.40) | 0.078 |